Daniel L Traber Selected Research

Smoke

4/2014	No correlation between initial arterial carboxyhemoglobin level and degree of lung injury following ovine burn and smoke inhalation.
12/2013	Antithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injury.
7/2013	Effect of bronchodilators on bronchial gland cell proliferation after inhalation and burn injury in sheep.
5/2013	Antithrombin attenuates myocardial dysfunction and reverses systemic fluid accumulation following burn and smoke inhalation injury: a randomized, controlled, experimental study.
12/2012	Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model.
12/2012	γ-tocopherol nebulization decreases oxidative stress, arginase activity, and collagen deposition after burn and smoke inhalation in the ovine model.
11/2012	Administration of a peroxynitrite decomposition catalyst into the bronchial artery attenuates pulmonary dysfunction after smoke inhalation and burn injury in sheep.
11/2012	Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.
9/2012	Development of a long-term ovine model of cutaneous burn and smoke inhalation injury and the effects of early excision and skin autografting.
7/2012	Assessment of combined muscarinic antagonist and fibrinolytic therapy for inhalation injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel L Traber Research Topics

Disease

73	Burns 05/2015 - 02/2002
56	Acute Lung Injury 12/2013 - 09/2002
51	Sepsis (Septicemia) 07/2014 - 03/2002
45	Smoke Inhalation Injury 04/2014 - 11/2002
23	Septic Shock (Toxic Shock Syndrome) 11/2012 - 07/2003
17	Airway Obstruction (Choking) 12/2013 - 02/2003
16	Lung Injury 04/2014 - 03/2003
14	Edema (Dropsy) 05/2015 - 09/2002
14	Pulmonary Edema 12/2012 - 02/2003
13	Wounds and Injuries (Trauma) 05/2014 - 02/2002
11	Inflammation (Inflammations) 05/2013 - 02/2003
11	Shock 12/2009 - 03/2002
10	Endotoxemia 11/2008 - 01/2003
8	Pneumonia (Pneumonitis) 07/2014 - 09/2002
8	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2011 - 11/2003
8	Hypotension (Low Blood Pressure) 11/2008 - 11/2003
7	Stroke (Strokes) 05/2013 - 11/2007
6	Hemorrhage 12/2013 - 01/2002
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2012 - 09/2007
3	Critical Illness (Critically Ill) 11/2011 - 05/2005
3	Peritonitis 01/2011 - 01/2009
2	Infections 04/2012 - 12/2008
2	Hyperemia 04/2011 - 07/2009

Drug/Important Bio-Agent (IBA)

72	SmokeIBA 04/2014 - 09/2002
23	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2013 - 06/2002
19	salicylhydroxamic acid (SHAM)IBA 04/2014 - 01/2004
18	Oxygen (Dioxygen)IBA 06/2011 - 01/2003
14	Saline SolutionIBA 12/2013 - 05/2005
10	CatecholaminesIBA 02/2009 - 01/2006
9	Arginine Vasopressin (Argipressin)IBA 07/2014 - 01/2006
9	Nitric Oxide Synthase (NO Synthase)IBA 12/2013 - 04/2003
9	Peroxidase (Myeloperoxidase)IBA 05/2013 - 08/2008
9	3-nitrotyrosineIBA 11/2012 - 05/2006
8	Proteins (Proteins, Gene)FDA Link 05/2015 - 12/2004
8	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2012 - 04/2003
6	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2012 - 02/2004
6	Tocopherols (Tocopherol)IBA 12/2012 - 12/2008
6	Vasopressins (Vasopressin)IBA 11/2012 - 01/2006
6	Peroxynitrous Acid (Peroxynitrite)IBA 11/2012 - 05/2006
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011 - 05/2006
6	Protein Isoforms (Isoforms)IBA 06/2011 - 02/2006
5	Arginine (L-Arginine)FDA Link 01/2014 - 03/2002
5	CytokinesIBA 05/2013 - 11/2005
5	Reactive Nitrogen SpeciesIBA 12/2012 - 08/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 01/2009
5	Protein CIBA 02/2012 - 09/2006
5	Malondialdehyde (Propanedial)IBA 02/2012 - 02/2011
5	drotrecogin alfa activated (Xigris)FDA Link 02/2012 - 09/2006
5	NitratesIBA 12/2011 - 11/2008
5	NitritesIBA 12/2011 - 11/2008
5	Superoxides (Superoxide)IBA 02/2011 - 02/2005
5	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2010 - 04/2008
5	Heparin (Liquaemin)FDA LinkGeneric 01/2009 - 09/2002
4	AntithrombinsIBA 12/2013 - 02/2003
4	Poly Adenosine Diphosphate RiboseIBA 06/2011 - 07/2003
4	Halothane (Fluothane)FDA Link 05/2011 - 12/2007
4	Vitamin E FDA LinkGeneric 12/2010 - 01/2006
4	NitrogenIBA 01/2010 - 07/2007
4	Pharmaceutical PreparationsIBA 01/2009 - 04/2003
4	EndotoxinsIBA 11/2008 - 01/2003
4	Adenosine Triphosphate (ATP)IBA 11/2007 - 11/2006
3	ArginaseIBA 12/2012 - 03/2011
3	CollagenIBA 12/2012 - 03/2011
3	AntioxidantsIBA 11/2011 - 08/2008
3	Isoflurane FDA LinkGeneric 06/2011 - 01/2002
3	AnticoagulantsIBA 02/2008 - 12/2007
3	TerlipressinIBA 01/2008 - 02/2005
3	FibrinIBA 01/2008 - 01/2007
3	PotassiumIBA 10/2007 - 11/2006
2	Hormones (Hormone)IBA 07/2014 - 11/2008
2	Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)- vasopressinIBA 07/2014 - 06/2012
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 07/2014 - 06/2012
2	CarboxyhemoglobinIBA 04/2014 - 05/2011
2	Interleukin-6 (Interleukin 6)IBA 05/2013 - 05/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012 - 08/2011
2	Messenger RNA (mRNA)IBA 11/2012 - 08/2008
2	Tiotropium Bromide (Spiriva)FDA Link 07/2012 - 12/2010
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2012 - 12/2010
2	Ethanol (Ethyl Alcohol)IBA 04/2012 - 11/2010
2	Ceftazidime (Fortum)FDA LinkGeneric 02/2012 - 07/2007
2	NeuropeptidesIBA 12/2011 - 01/2008
2	7-nitroindazoleIBA 12/2011 - 04/2008
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2011 - 03/2011
2	EnzymesIBA 08/2011 - 07/2003
2	Blood Proteins (Serum Proteins)IBA 12/2009 - 01/2007
2	GasesIBA 11/2009 - 05/2006
2	Interleukin-8 (Interleukin 8)IBA 01/2009 - 01/2009

Therapy/Procedure

16	Therapeutics 07/2014 - 02/2002
11	Anesthesia 12/2012 - 01/2006
4	Critical Care (Surgical Intensive Care) 11/2010 - 02/2003
4	Mechanical Ventilators (Ventilator) 01/2008 - 01/2006
4	Resuscitation 06/2006 - 08/2002
3	Autologous Transplantation 09/2012 - 12/2008
3	Ligation 05/2011 - 01/2004
3	Catheters 11/2010 - 01/2004
2	Injections 07/2013 - 11/2007
2	Microspheres (Microsphere) 07/2013 - 11/2010
2	Intravenous Infusions 05/2013 - 05/2005
2	Skin Transplantation (Skin Grafting) 09/2012 - 12/2008
2	Tracheostomy 10/2011 - 06/2006